Seminar Poster

Speaker:
Professor Paul Pharoah
Professor of Cancer Epidemiology
Strangeways Research Laboratory
University of Cambridge, UK

About the Speaker:
Professor Pharoah qualified in Medicine from the University of Oxford in 1986. After a series of posts in internal medicine he worked for a year in Malawi on a leprosy vaccine trial. Then he completed his training in public health medicine before taking up a post as research fellow in the CRC Human Cancer Genetics group at the University of Cambridge in 1996. Having completed his doctoral studies in 1999 he won a Cancer Research UK Senior Clinical Research Fellowship. In 2004 his fellowship was renewed and he was successful in obtaining programme grant funding. On completion of his fellowship in 2009 he was appointed Reader in Cancer Epidemiology and then promoted to a personal Chair in 2012.

The major themes of the research programme of Professor Pharoah’s group are:

1. Genetic susceptibility to ovarian cancer.
2.The role of germline genetic variation in determining clinical outcome after a diagnosis of breast or ovarian cancer.
3. The molecular pathology of breast and ovarian cancer.
4. SEARCH – an ongoing study of genetic susceptibility to the common cancers.

Abstract:
PREDICT is an online prognostication and treatment benefit tool designed to help clinicians and patients make informed decisions about treatment following breast cancer surgery. The survival estimates, presented both with and without adjuvant therapy (hormone therapy, chemotherapy and trastuzumab), are provided for 5 and 10 years following surgery. Development of the model was a collaborative project between the Cambridge Breast Unit, University of Cambridge Department of Oncology and the Eastern Cancer Information and Registration Centre (ECRIC). (http://www.predict.nhs.uk).

CME Accreditation:

* One CME point for attendance by the Hong Kong Academy of Medicine (Pathologists)
* One CME point for attendance by the Medical Council of Hong Kong (MCHK). [ Activity No. 3579 ]
* One CPD point for attendance by the Medical Laboratory Technologists Board [ Activity No. 13180111 ]

All are welcome.
For enquiries, please contact Mr Jonathan Lee at 3763 6005.